Professor Richard Kefford AM
Rick is a professor of Cancer Medicine at Macquarie University, Adjunct Professor in Medicine at the University of Sydney, and Consultant Medical Oncologist in breast cancer and melanoma at Westmead and Macquarie University Hospitals. He is Co-Director of Research at Melanoma Institute Australia (MIA). He is Chief Investigator on NHMRC and CINSW Program Grants researching the molecular biology of melanoma, with particular focus on melanoma genomics. He has been an investigator on over 50 Phase I, II , III and adjuvant Clinical Trials in melanoma and breast cancer, including the recent development of targeted therapies and immunotherapy.
He is a member of the Australian NHMRC Research Translation Faculty Cancer Steering Group and has served as a member of its Academy, Research Committee, and Project and Program Research Committees. He is a Member of the Ethics Committee of the Medical Oncology Group of Australia (MOGA). He serves as a consultant to multiple biotechnology and pharmaceutical companies on melanoma drug development and clinical trials. He was awarded as Member of the Order of Australia in 2009 for services to medicine in the area of oncology research, to professional organisations, and as an educator.